Jacob Sands
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 54
- Lung Cancer Research Studies 43
- Peptidase Inhibition and Analysis 11
- Cancer Immunotherapy and Biomarkers 7
- HER2/EGFR in Cancer Research 7
-
- Lung Cancer Treatments and Mutations 33
- Lung Cancer Diagnosis and Treatment 9
- Co-authors
- Aaron Lisberg (23 shared papers)Shetal Patel (2 shared papers)Rebecca S. Heist (15 shared papers)Kiyotaka Yoh (12 shared papers)Noboru Yamamoto (10 shared papers)Toshio Shimizu (10 shared papers)Funda Meric‐Bernstam (9 shared papers)Alexander I. Spira (13 shared papers)
- Journals
- Journal of Clinical Oncology (24 papers)Annals of Oncology (11 papers)Journal of Thoracic Oncology (9 papers)Lung Cancer (6 papers)JCO Precision Oncology (3 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Jacob Sands
77 papers receiving 1.1k citations
Jacob Sands's Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 608
- Pulmonary and Respiratory Medicine 431
- Cancer Research 137
- Radiology, Nuclear Medicine and Imaging 153
- Molecular Biology 193
Countries citing papers authored by Jacob Sands
This map shows the geographic impact of Jacob Sands's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Sands with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Sands more than expected).
Fields of papers citing papers by Jacob Sands
This network shows the impact of papers produced by Jacob Sands. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Sands. The network helps show where Jacob Sands may publish in the future.
Co-authors
The 25 scholars most cited alongside Jacob Sands, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2–Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non–Small-Cell Lung Cancer: TROPION-PanTumor01 Hit paper breakdown → | 2023 | 93 |
| 2 | 2020 | 79 | |
| 3 | 2021 | 47 | |
| 4 | 2021 | 41 | |
| 5 | 2023 | 39 | |
| 6 | 2024 | 35 | |
| 7 | 2019 | 34 | |
| 8 | 2023 | 34 | |
| 9 | 2022 | 33 | |
| 10 | 2023 | 33 | |
| 11 | 2020 | 28 | |
| 12 | 2009 | 28 | |
| 13 | 2021 | 26 | |
| 14 | 2021 | 26 | |
| 15 | 2017 | 25 | |
| 16 | 2016 | 25 | |
| 17 | 2020 | 24 | |
| 18 | 2020 | 24 | |
| 19 | 2021 | 23 | |
| 20 | 2014 | 22 |
About Jacob Sands
Jacob Sands is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Epidemiology, having authored 83 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (43 papers), Lung Cancer Treatments and Mutations (33 papers), Cancer therapeutics and mechanisms (15 papers), Peptidase Inhibition and Analysis (11 papers), Lung Cancer Diagnosis and Treatment (9 papers), Cancer Genomics and Diagnostics (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and HER2/EGFR in Cancer Research (7 papers). The work is most often cited by research in Oncology (608 citations), Pulmonary and Respiratory Medicine (431 citations), Cancer Research (137 citations), Radiology, Nuclear Medicine and Imaging (153 citations) and Molecular Biology (193 citations). Jacob Sands has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Aaron Lisberg, Shetal Patel, Rebecca S. Heist, Kiyotaka Yoh, Noboru Yamamoto, Toshio Shimizu, Funda Meric‐Bernstam, Alexander I. Spira, Melissa L. Johnson and Erik H. Knelson. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, Lung Cancer and JCO Precision Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.